Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 28, 2004

Primary Completion Date

July 17, 2006

Study Completion Date

July 17, 2006

Conditions

Angioedema

Interventions

DRUG

Icatibant

30 mg (3mL) subcutaneous icatibant injection in the abdominal region

DRUG

Placebo

Solution for injection, matched to study drug Single dose: 3 mL

Trial Locations (1)

Georgetown University Hospital, Lombardi Cancer Center, Washington D.C.